348 related articles for article (PubMed ID: 29981390)
1. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.
Tolkachjov SN; Kelley BF; Alahdab F; Erwin PJ; Brewer JD
J Am Acad Dermatol; 2018 Nov; 79(5):929-934.e6. PubMed ID: 29981390
[TBL] [Abstract][Full Text] [Related]
2. Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database.
Singh B; Qureshi MM; Truong MT; Sahni D
J Am Acad Dermatol; 2018 Jul; 79(1):126-134.e3. PubMed ID: 29408552
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous mesenchymal tumors treated with Mohs micrographic surgery: a comprehensive review.
Rosenfeld DJ; Cappel MA; Tolkachjov SN
Int J Dermatol; 2021 Nov; 60(11):1334-1342. PubMed ID: 33715156
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
5. Time to recurrence after surgical excision of atypical fibroxanthoma-updated systematic review and meta-analysis.
Phan K; Onggo J
Australas J Dermatol; 2019 Aug; 60(3):e220-e222. PubMed ID: 30793288
[TBL] [Abstract][Full Text] [Related]
6. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
7. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans.
Malan M; Xuejingzi W; Quan SJ
Pan Afr Med J; 2019; 33():297. PubMed ID: 31692830
[TBL] [Abstract][Full Text] [Related]
9. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
10. Surgical excision margins for fibrohistiocytic tumors, including atypical fibroxanthoma and undifferentiated pleomorphic sarcoma: A probability model based on a systematic review.
Jibbe A; Worley B; Miller CH; Alam M
J Am Acad Dermatol; 2022 Oct; 87(4):833-840. PubMed ID: 34587553
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Atypical Fibroxanthoma Versus Malignant Fibrous Histiocytoma.
Branch LG; Albertini JG; Leshin B
J Craniofac Surg; 2015 Jun; 26(4):e322-3. PubMed ID: 26080249
[TBL] [Abstract][Full Text] [Related]
12. Atypical fibroxanthoma management: Recurrence, metastasis and disease-specific death.
Polcz MM; Sebaratnam DF; Fernández-Peñas P
Australas J Dermatol; 2018 Feb; 59(1):10-25. PubMed ID: 28815551
[TBL] [Abstract][Full Text] [Related]
13. Atypical fibroxanthoma/malignant fibrous histiocytoma.
Marcet S
Dermatol Ther; 2008; 21(6):424-7. PubMed ID: 19076618
[TBL] [Abstract][Full Text] [Related]
14. Wide local excision vs. Mohs Tübingen technique in the treatment of dermatofibrosarcoma protuberans: a two-centre retrospective study and literature review.
Veronese F; Boggio P; Tiberio R; Gattoni M; Fava P; Caliendo V; Colombo E; Savoia P
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2069-2076. PubMed ID: 28573714
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic dermal sarcoma: a retrospective study of 16 cases in a dermato-oncology centre and a review of the literature.
Ríos-Viñuela E; Serra-Guillén C; Llombart B; Requena C; Nagore E; Traves V; Guillén C; Vázquez D; Sanmartín O
Eur J Dermatol; 2020 Oct; 30(5):545-553. PubMed ID: 33021478
[TBL] [Abstract][Full Text] [Related]
16. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
Cumberland L; Dana A; Liegeois N
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data.
Ørholt M; Aaberg FL; Abebe K; Walsh S; Roenigk RK; Venzo A; Schmidt G; Klyver H; Jensen DH; Herly M; Vester-Glowinski PV
J Surg Oncol; 2022 Sep; 126(3):555-562. PubMed ID: 35441377
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.
Zhou C; Wu F; Chai P; Shi Y; Ye J; Shi X; Tan J; Ding Y; Luo Y; Esmaeli B; Jia R; Fan X
J Am Acad Dermatol; 2019 Jun; 80(6):1608-1617.e1. PubMed ID: 30639290
[TBL] [Abstract][Full Text] [Related]
19. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma.
Davis JL; Randle HW; Zalla MJ; Roenigk RK; Brodland DG
Dermatol Surg; 1997 Feb; 23(2):105-10. PubMed ID: 9107284
[TBL] [Abstract][Full Text] [Related]
20. Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience.
McCoppin HH; Christiansen D; Stasko T; Washington C; Martinez JC; Brown MD; Zwald FO
Dermatol Surg; 2012 Feb; 38(2):230-9. PubMed ID: 22129349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
